| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/23/2005 | EP1507794A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/23/2005 | EP1311280A4 Cell internalized peptide-drug conjugates |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585766A Dimeric compounds and their use as anti-viral agents |
| 02/23/2005 | CN1585757A Oligopeptides and compositions containing them as cathepsin S inhibitors |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858577 For therapy of thrombosis, restenosis, hypertension, heart failure, arrhythmia, inflammation, angina, stroke, atherosclerosis, ischemic conditions, Angiogenesis related disorders, cancer, and neurodegenerative disorders |
| 02/22/2005 | US6858396 Amino acids where primary amine group is replaced by azide; use in peptides screening for bioactivity, crossing blood-brain barrier, increasing selectivity; treating brain disorders |
| 02/17/2005 | WO2005014619A2 Heparin-binding peptides and uses thereof |
| 02/17/2005 | WO2004099135A3 Hiv prodrugs cleavable by cd26 |
| 02/17/2005 | WO2004083236A3 Cancer treatment using proanp peptides |
| 02/17/2005 | US20050038234 Bi-functionalised metallocenes use for marking biological molecules |
| 02/17/2005 | US20050038233 obtaining a sequence-defined molecular weight markers that provide an accurate and robust calibration set for determinations of molecular weight of production batches; subjecting the molecular weight markers to column chromatography to establish a relationship between retention time and molecular weight |
| 02/17/2005 | US20050038230 For decreasing food intake; eating disorders; sexual disorders |
| 02/17/2005 | US20050038109 treatment of solid tumor cancers |
| 02/17/2005 | US20050038029 Transferring, releasing nitric oxide; side effect reduction; using a compound containing nitrosos group |
| 02/17/2005 | US20050038012 use in improvement of gastrointestinal blood flow, in treatment of hypertension and in treatment and prophylaxis of cardiac damages induced by adriamycin and comparable anti-cancer drugs |
| 02/17/2005 | US20050037977 Compounds for treating tumors |
| 02/17/2005 | US20050037475 Method of purifying TFPI and TFPI analogs |
| 02/17/2005 | US20050037453 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method |
| 02/17/2005 | US20050037432 Macroglobulin peptides for use as diagnostic indicator of osteoarthritis, bone and tissue disorders |
| 02/17/2005 | US20050037430 creating a peptide database by screening, analyzing the results, characterizing a physical, chemical, or biological property of the peptides, recording; using a computer for presenting biomolecular sequence data; regulatory activity on pro- or anti-inflammatory cytokine cascades; immunoresponse |
| 02/17/2005 | US20050036980 cell adhesion promoting (CAP) peptide combinations that promote cell attachment or cell adhesion to culture surfaces that are otherwise cell adhesion resistant CAR); peptides when coupled to a CAR layer such as hyaluronic acid that has been created on a polymer surface, promote cell growth |
| 02/17/2005 | CA2534658A1 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/16/2005 | EP1506970A1 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same |
| 02/16/2005 | EP1506969A1 Compounds with growth hormone releasing properties |
| 02/16/2005 | EP1506219A2 Novel process for production of the somatostatin analog, octreotide |
| 02/16/2005 | EP1506172A2 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1506168A2 Gelling agents |
| 02/16/2005 | EP1506000A1 Heterocyclicsulfonamide hepatitis c virus inhibitors |
| 02/16/2005 | EP1505963A1 Hepatitis c virus inhibitors |
| 02/16/2005 | EP1505945A2 Substituted cycloalkyl p1' hepatitis c virus inhibitors |
| 02/16/2005 | EP1294741B1 Dipeptide inhibitors for the blood-clotting factor xa |
| 02/16/2005 | CN1582302A Dermopharmaceutically and cosmetically active oligopeptides |
| 02/16/2005 | CN1582296A Template-fixed peptidomimeticsas inhibitors of serine proteases |
| 02/16/2005 | CN1189476C New thrombin inhibitors, their preparation and use |
| 02/16/2005 | CN1189166C FC receptor modulators and uses thereof |
| 02/15/2005 | US6855696 Antitumor agents |
| 02/15/2005 | US6855693 Peptide for use in the treatment of cell damage caused by ischemia |
| 02/15/2005 | US6855692 Histogranin peptides and their analgesic use |
| 02/15/2005 | US6855689 Anticancer agents |
| 02/15/2005 | US6855496 Detection of preferential nucleic acid ligands; obtain nucleotide sequences, incubate with oligonucleotides, hybridize, amplify, recover nucleotide sequences |
| 02/10/2005 | WO2005012542A1 Casein hydrolyzate, process for producing the same and use thereof |
| 02/10/2005 | WO2005012334A1 Biologically non-degradable peptide, angiotensin converting enzyme inhibitor, drug and functional food |
| 02/10/2005 | WO2005012333A2 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 02/10/2005 | WO2005012332A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 02/10/2005 | WO2005012331A1 Spatially-defined macrocyclic compounds useful for drug discovery |
| 02/10/2005 | WO2005012328A2 Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof |
| 02/10/2005 | WO2005011607A2 Treatment of cancers expressing p95 erbb2 |
| 02/10/2005 | WO2004093903A3 Methods and compositions for immunomodulation using cd1 antigens |
| 02/10/2005 | WO2004058188A3 Vaccine compositions and methods |
| 02/10/2005 | WO2003099338A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues |
| 02/10/2005 | WO2003063760A3 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 02/10/2005 | US20050032709 Anti-hypertensive molecules and process for preparation thereof |
| 02/10/2005 | US20050032707 Novel peptides comprising furanoid sugar amino acids for the treatment of cancer |
| 02/10/2005 | US20050032706 Hypoglycaemic peptides and methods of use thereof |
| 02/10/2005 | US20050032190 Beta-secretase substrates and uses thereof |
| 02/10/2005 | US20050031582 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 02/10/2005 | DE3823105B4 Dolastatin 10, Verfahren zu seiner Gewinnung, und es enthaltende pharmazeutische Zusammensetzungen Dolastatin 10, process for its production, and pharmaceutical compositions containing it |
| 02/10/2005 | DE19845403B4 Mit Gallensäuren verknüpfte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung With bile acids linked Propanolaminderivate, processes for their preparation, pharmaceutical compositions containing them and their use |
| 02/10/2005 | CA2574733A1 Method for the production of cyclic molecules |
| 02/10/2005 | CA2546497A1 Casein hydrolyzate, process for producing the same and use thereof |
| 02/10/2005 | CA2533820A1 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 02/10/2005 | CA2533818A1 Spatially-defined macrocyclic compounds useful for drug discovery |
| 02/10/2005 | CA2532537A1 Biologically non-degradable peptides and their use as angiotensin converting enzyme inhibitors, drugs and functional foods |
| 02/09/2005 | EP1505062A1 Heterocyclic derivatives and their use as antithrombotic agents |
| 02/09/2005 | EP1504033A2 Connective tissue stimulating peptides |
| 02/09/2005 | EP1504024A1 Thermostable and monoconjugatable gold cluster complexes |
| 02/09/2005 | EP1503792A2 Attenuation of metapneumovirus |
| 02/09/2005 | EP1503749A2 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 02/09/2005 | EP1080104B1 Certain heteroaryl substituted thiol inhibitors of endothelin-converting enzyme |
| 02/09/2005 | CN1578786A Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 02/08/2005 | US6852875 Synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using oxazolidinone derivatives |
| 02/08/2005 | US6852744 Pyrrolidine derivatives and their use as chymase inhibitor |
| 02/08/2005 | US6852699 Effective content of one or more monomeric or homo- or heterodimeric or homo- or heterotrimeric or homo- or heterotetrameric oligopeptides, where these oligopeptides are based on a structure Val-Val-Arg-Pro as homo- or |
| 02/08/2005 | US6852697 Peptides for treatment of inflammation and shock |
| 02/08/2005 | CA2096525C Retroviral protease inhibitors |
| 02/08/2005 | CA2096409C Retroviral protease inhibitors |
| 02/08/2005 | CA2096408C Retroviral protease inhibitors |
| 02/03/2005 | WO2005010205A2 Biomarkers fo aggrecanase activity |
| 02/03/2005 | WO2005010029A1 Aza-peptide macrocyclic hepatitis c serine protease inhibitors |
| 02/03/2005 | WO2005010028A1 Alpha-amino acid benzothiazolylthio ester as intermediates for manufacture of ace inhibitors and process for preparation thereof |
| 02/03/2005 | WO2005010027A2 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/03/2005 | WO2005009455A1 Peptide compound exhibiting an immunoregulatory property |
| 02/03/2005 | WO2005009363A2 Treatment of pre-cancerous conditions and prevention of cancer using pcdgf-based therapies |
| 02/03/2005 | WO2005009217A2 Diagnosis of pre-cancerous conditions using pcdgf agents |
| 02/03/2005 | WO2004012574A3 Negative selections assays, and compositions thereof |
| 02/03/2005 | WO2003064620A3 Hepsin substrates and prodrugs |
| 02/03/2005 | US20050026994 Treating proliferative diseases such as tumors; 4-[4-(2-Benzyloxycarbonylamino-3-methyl-butyrylamino)-3-hydroxy-2-(4-methoxy-benzylamino)-5-phenyl-pentanoylamino]4-(2-hydroxy-4-methoxy-benzylcarbamoyl)-butyric acid methyl ester for example |
| 02/03/2005 | US20050026845 Pharmaceutical/cosmetic compositions comprising the lysine-D-proline-valine tripeptide |
| 02/03/2005 | US20050026840 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or pertidomimetics |
| 02/03/2005 | US20050026835 Methods of treating non-inflammatory gastrointestinal tract disorders using Cav2.2 subunit calcium channel modulators |
| 02/03/2005 | US20050025821 Lipid-comprising drug delivery complexes and methods for their production |
| 02/03/2005 | US20050025723 Topical formulation containing melanocyte stimulating hormone and/or derivative in carrier |
| 02/03/2005 | US20050025709 Immunological reagents for therapeutic use, for example, in radioimmunotherapy (RAIT), and diagnostic use, for example, in radioimmunodetection (RAID) and magnetic resonance imaging |
| 02/03/2005 | CA2532869A1 Novel peptidic conjugates for alopecia preventive and curative treatment |
| 02/02/2005 | EP1501935A2 Low-cost production of peptides |
| 02/02/2005 | EP1461620A4 Flexible method and apparatus for high throughput production and purification of multiple proteins |
| 02/02/2005 | EP1351980A4 Peptides for activation and inhibition of delta pkc |
| 02/02/2005 | EP1284991B1 Synthesis of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester using oxazolidinone derivatives |